19942023年云南省玉溪市甲型病毒性肝炎流行病学分析

Epidemiological analyses of hepatitis A in Yuxi City of Yunnan Province from 1994 to 2023

  • 摘要:
    目的 分析1994—2023年甲型病毒性肝炎(简称“甲肝”)减毒活疫苗纳入扩大免疫规划(EPI)前(1994—2008年)后(2009—2023年)云南省玉溪市的报告病例特征和发病率,为制定甲肝防控策略提供依据。
    方法 从云南省玉溪市疫情资料汇编和中国疾病监测信息报告管理系统,收集玉溪市1994—2023年甲肝报告病例的相关资料。采用描述性流行病学分析方法,描述玉溪市1994—2023年和EPI前后甲肝报告病例的年龄和职业构成,以及不同时间、性别、地区的发病率。用集中度(M)分析法分析甲肝发病的季节性。
    结果 1994—2023年玉溪市共报告甲肝病例6 028例。各年龄段均有甲肝报告病例,病例占比随年龄增长而下降。EPI后,30~<45岁病例占比最高(26.48%)。EPI前,甲肝病例的职业以学生为主(37.20%),EPI后以农民为主(48.73%)。1994—2023年玉溪市甲肝年均报告发病率为9.75/10万。报告发病率总体呈逐年下降趋势(χ趋势2=3 566.82,P<0.001),年均报告发病率从EPI前的16.78/10万降至EPI后的2.72/10万。甲肝发病的季节性不明显(1994—2023年,M=0.184;EPI前,M=0.207;EPI后,M=0.059)。男性甲肝报告发病率(11.47/10万)高于女性(7.98/10万)。1994—2023年玉溪市累计报告发病率居前3位的县(市、区)是通海县(18.41/10万)、峨山彝族自治县(15.42/10万)、江川区(10.34/10万)。EPI后,各地区甲肝报告发病率均大幅下降,平均报告发病率由17.50/10万降至2.31/10万。按照国内生产总值(GDP)水平将玉溪市9个县(市、区)分为3类地区,甲肝报告发病率随地区GDP水平上升而降低。
    结论 玉溪市将甲肝疫苗纳入EPI后,甲肝发病率下降。EPI实施后,玉溪市甲肝报告病例中30~<45岁者、农民占比较高。男性是甲肝防控的重点人群,GDP水平较低的地区是甲肝防控的重点地区。建议在重点地区、重点人群中进一步扩大疫苗覆盖面,同时加强卫生健康教育与环境改善,以巩固防控效果,缩小地区发病水平差异。

     

    Abstract:
    Objective To analyze the reported‑case characteristics and incidence of hepatitis A in Yuxi City of Yunnan Province before (1994‒2008) and after (2009‒2023) the live attenuated hepatitis A vaccine was incorporated into the expanded program on immunization (EPI), to provide a basis for formulating hepatitis A prevention and control strategies.
    Methods Data on reported hepatitis A cases in Yuxi City of Yunnan Province from 1994 to 2023 were collected from the Yuxi City Epidemic Data Compilation and the China Disease Surveillance Information Reporting Management System. Descriptive epidemiological analyses were used to characterize age distribution, occupational composition, and incidence rates across different time periods, genders, and region of the reported hepatitis A cases in Yuxi City from 1994 to 2023 as well as before and after the EPI. Concentration ratio (M) analysis methods were employed to analyze the seasonality of hepatitis A incidence.
    Results From 1994 to 2023, a total of 6 028 cases of hepatitis A were reported in Yuxi City. Hepatitis A cases were reported across all age groups, with the proportion of cases decreasing as age increased. After the implementation of the EPI, the highest proportion of cases was observed in the 30 to under 45 years old age group (26.48%). Before the EPI, students constituted the majority of hepatitis A cases (37.20%), while after the EPI, farmers became the predominant group (48.73%). From 1994 to 2023, the average annual reported incidence rate of hepatitis A in Yuxi City was 9.75/100 000. The overall reported incidence rate showed a declining trend year by year (χ²Trend=3 566.82, P<0.001), with the average annual reported incidence decreasing from 16.78/100 000 before the EPI to 2.72/100 000 after the EPI. The seasonality of hepatitis A incidence was not pronounced (1994‒2023: M=0.184; pre-EPI: M=0.207; post-EPI: M=0.059). The reported incidence rate was higher in males (11.47/100 000) than that in females (7.98/100 000). From 1994 to 2023, the top three counties (cities and districts) in Yuxi City with the highest cumulative reported incidence rates were Tonghai County (18.41/100 000), Eshan Yi Autonomous County (15.42/100 000), and Jiangchuan District (10.34/100 000). After the EPI, the reported incidence rates of hepatitis A declined significantly across all regions, with the average reported incidence rate dropping from 17.50/100 000 to 2.31/100 000. Based on gross domestic product (GDP) levels, the nine counties (cities and districts) of Yuxi City were categorized into three types of regions, and the reported incidence rate of hepatitis A decreased as the regional GDP level increased.
    Conclusion Following the inclusion of hepatitis A vaccines in the EPI in Yuxi City, the reported incidence rate of hepatitis A declined. Farmers and individuals aged 30 to under 45 years old constituted higher proportions of hepatitis A cases. Men were the key population for hepatitis A prevention and control, while regions with lower GDP levels were the priority areas for hepatitis A interventions. It is recommended to further expand vaccine coverage in these key regions and among key populations, while simultaneously strengthening health education and environmental improvements to consolidate prevention outcomes and abbreviate regional incidence disparities.

     

/

返回文章
返回